ARCHIVES

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

Et2’s Referral Guidelines

July 23, 1993

Nurse Participation In International Congress Increases

September 19, 1986

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson In U.S. News & World Report Ranking

July 18, 2014

Professional Societies: AACI Seeks To Define Role Of Cancer Centers In Washington Politics

October 16, 1998

In Brief: Arkansas, Iowa Appoint Center Directors; Broder Moves To Gene Sequencing Venture

August 14, 1998